Status:
UNKNOWN
Ongoing WARfarin and Coronary STENTing
Lead Sponsor:
War-Stent Investigators
Conditions:
Acute Coronary Syndrome
Atrial Fibrillation
Eligibility:
All Genders
Brief Summary
Patients on warfarin treatment pose particular problems when undergoing percutaneous coronary intervention with stent implantation (PCI-S), because of the poor definition of the optimal antithrombotic...
Detailed Description
Patients on oral anticoagulation with vitamin-K antagonists who undergo PCI-S will be prospectively included in the registry and follow up for 12 months
Eligibility Criteria
Inclusion
- Patients with ongoing warfarin treatment.
Exclusion
- None
Key Trial Info
Start Date :
March 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2011
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT00722319
Start Date
March 1 2009
End Date
October 1 2011
Last Update
August 12 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Division of Cardiology
Bologna, Italy, 40133